| # | Drug | Count |
|---|---|---|
| 0 | DUPILUMAB | 17 |
| 1 | ALBUTEROL SULFATE | 14 |
| 2 | OMEPRAZOLE MAGNESIUM | 14 |
| 3 | RITONAVIR | 13 |
| 4 | DARUNAVIR | 12 |
| 5 | METHOTREXATE SODIUM | 12 |
| 6 | OMEPRAZOLE | 12 |
| 7 | PONATINIB HYDROCHLORIDE | 12 |
| 8 | PREDNISONE | 12 |
| 9 | CLOFAZIMINE | 11 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ABACAVIR AND LAMIVUDINE | 1 | 0.0050 |
| 1 | GRISEOFULVIN | 1 | 0.0034 |
| 2 | NITAZOXANIDE | 1 | 0.0029 |
| 3 | PONATINIB HYDROCHLORIDE | 12 | 0.0023 |
| 4 | EPINEPHRINE INHALATION | 1 | 0.0020 |
| 5 | ELIGLUSTAT | 3 | 0.0018 |
| 6 | CLOFAZIMINE | 11 | 0.0017 |
| 7 | OMADACYCLINE | 2 | 0.0012 |
| 8 | DACARBAZINE | 8 | 0.0011 |
| 9 | VINBLASTINE SULFATE | 2 | 0.0010 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 38 |
| 1 | Interleukin-4 Receptor alpha Antagonist [EPC] | 17 |
| 2 | Proton Pump Inhibitor [EPC] | 14 |
| 3 | Cytochrome P450 3A Inhibitor [EPC] | 13 |
| 4 | Nonsteroidal Anti-inflammatory Drug [EPC] | 13 |
| 5 | Protease Inhibitor [EPC] | 13 |
| 6 | Vitamin C [EPC] | 12 |
| 7 | Alkylating Drug [EPC] | 11 |
| 8 | Antimycobacterial [EPC] | 11 |
| 9 | Folate Analog Metabolic Inhibitor [EPC] | 11 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Tubulin Inhibiting Agent [EPC] | 1 | 0.0034 |
| 1 | Glucosylceramide Synthase Inhibitor [EPC] | 3 | 0.0011 |
| 2 | Neonatal Fc Receptor Blocker [EPC] | 4 | 0.0009 |
| 3 | Tetracycline-class Antibacterial [EPC] | 4 | 0.0005 |
| 4 | Interleukin-17 Receptor A Antagonist [EPC] | 1 | 0.0005 |
| 5 | Sulfone [EPC] | 5 | 0.0005 |
| 6 | Antimycobacterial [EPC] | 11 | 0.0005 |
| 7 | Progesterone [EPC] | 10 | 0.0004 |
| 8 | Interleukin-1 Receptor Antagonist [EPC] | 7 | 0.0004 |
| 9 | Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 9 | 0.0004 |